ADLI American Medical Technologies Inc (CE)

Table of Contents

UNITED STATES SECURITIES AND EXCHANGE

COMMISSION

WASHINGTON, DC 20549

FORM 10-Q

For the transition period from                  to

Commission file number 0-19195

AMERICAN MEDICAL TECHNOLOGIES, INC.

(Exact Name of Registrant as Specified in Its Charter)

Registrant’s Telephone Number, Including Area Code: (361) 289-1145

Former Name, Former Address and Former Fiscal Year, if Changed Since Last Report: Not Applicable

Indicate by check mark whether the registrant: (1) has filed all reports required to be filed by Section 13 or 15(d) of the Securities Exchange Act of 1934 during the preceding 12 months (or for such shorter period that the registrant was required to file such reports), and (2) has been subject to such filing requirements for the past 90 days. Yes      x       No      o

Indicate by check mark whether the registrant is a large accelerated filer, an accelerated filer, a non-accelerated filer, or a smaller reporting company. See definitions of “large accelerated filer,” “accelerated filer,” and “smaller reporting company” in Rule 12b-2 of the Exchange Act. (Check one):

Indicate by check mark whether the registrant is a shell company (as defined in Rule 12b-2 of the Exchange Act). Yes    o    No    x

Indicate the number of shares outstanding of each of the issuer’s classes of common stock, as of the latest practicable date.

Table of Contents

AMERICAN MEDICAL TECHNOLOGIES, INC.

REPORT ON FORM 10-Q

QUARTER ENDED JUNE 30, 2008

TABLE OF CONTENTS

2

Table of Contents

AMERICAN MEDICAL TECHNOLOGIES, INC.
CONDENSED CONSOLIDATED BALANCE SHEETS

See accompanying notes to condensed consolidated financial statements.

3

Table of Contents

AMERICAN MEDICAL TECHNOLOGIES, INC.

CONDENSED CONSOLIDATED STATEMENTS OF OPERATIONS

(Unaudited)

See accompanying notes to condensed consolidated financial statements.

4

Table of Contents

AMERICAN MEDICAL TECHNOLOGIES, INC.

CONDENSED CONSOLIDATED STATEMENTS OF CASH FLOWS

(Unaudited)

See accompanying notes to condensed consolidated financial statements.

5

Table of Contents

American Medical Technologies, Inc.

Notes to Interim Condensed Consolidated Financial Statements

1.      Basis of Presentation and Other Accounting Information

Basis of Presentation

The accompanying unaudited condensed consolidated financial statements of American Medical Technologies, Inc. (the “Company” or “AMT”) have been prepared by management in accordance with accounting principles generally accepted in the United States of America for interim financial information and with the instructions to Form 10-Q and Article 8 of Regulation S-X and with the presumption that the Company will continue as a going concern.  Accordingly, they do not include all information and footnotes required by generally accepted accounting principles for complete financial statements.  In the opinion of management, all adjustments (consisting of normal recurring accruals) considered necessary for a fair presentation have been included.

The results of operations for the three and six months ended June 30, 2008 are not necessarily indicative of the results to be expected for the year ending December 31, 2008.  The accompanying unaudited consolidated financial statements should be read with the annual consolidated financial statements and notes contained in the Company’s Annual Report on Form 10-KSB for the fiscal year ended December 31, 2007.

Liquidity

The Company’s financial statements are prepared using accounting principles generally accepted in the United States of America applicable to a going concern, which contemplates the realization of assets and the satisfaction of liabilities in the normal course of business.  The Company incurred an operating loss of ($245,172) and ($387,494) for the six month periods ended June 30, 2008 and June 30, 2007, respectively.  The Company’s recurring losses from operations and the Company’s total liabilities exceeding its total assets raise substantial doubt as to the Company’s ability to continue as a going concern.  The Company believes that increases in revenue and gross margin due to the addition of new product line representations and additional funds available from the line of credit will alleviate the doubt about the Company’s ability to continue as a going concern; however, no assurances can be made.

Inventories

Inventories consist of the following:

The Company’s reserve for slow moving inventory is evaluated periodically based on its current and projected sales and usage.  The inventory reserve calculation assumes that any parts on hand exceeding three years of projected usage are subject to complete valuation allowance.

The Company recorded a $54,416 decrease to the reserve for the six months ended June 30, 2008.  The Company’s reserve for slow moving inventory was approximately $937,000 at June 30, 2008.  The valuation allowance could change materially, either up or down, if actual parts usage in future years is

6

Table of Contents

materially different than the usage projected at June 30, 2008; however, the new cost basis cannot subsequently be marked up based on changes in underlying facts and circumstances.

Earnings Per Share - The following table sets forth the computation for basic and diluted earnings per share:

Potentially dilutive securities include options and warrants.  For the periods ended June 30, 2008 and June 30, 2007 there were approximately 4,721,680 and 5,196,928 shares respectively issuable in connection with these potentially dilutive securities.  The potentially dilutive securities were excluded from the computations of diluted net income (loss) per share for each period because their effect would have been antidilutive.  The computation of diluted earnings per share for June 30, 2007 excludes the effect of assuming the conversion of the 400,000 shares of Preferred Stock which were convertible for two and one-half shares of common stock because the effect would have been antidilutive.

Fair Value Measurement – We adopted SFAS 157 effective January 1, 2008 for financial assets and liabilities measured on a recurring basis.  SFAS 157 applies to all financial assets and financial liabilities that are being measured and reported on a fair value basis.  In February 2008, the FASB issues FSP 157-2, which delayed the effective date of SFAS 157 to fiscal years beginning after November 15, 2008 for nonfinancial assets and liabilities.  Fair value, as defined in SFAS 157, is the price that would be received to sell an asset or paid to transfer a liability in an orderly transaction between market participants at the measurement date.  SFAS 157 affects the Company in the fair value measurement of the commodity and interest rate derivative positions which must be classified in one of the following categories:

Level 1 Inputs

These inputs come from quoted prices (unadjusted) in active markets for identical assets or liabilities.

Level 2 Inputs

These inputs are other than quoted prices that are observable, for an asset or liability.  This includes:  quoted prices for similar assets or liabilities in active markets; quoted prices for identical or similar assets or liabilities in markets that are not active; inputs other than quoted prices that are observable for the asset

7

Table of Contents

or liability; and inputs that are derived principally from our corroborated by observable market data by correlation or other means.

Level 3 Inputs

These are unobservable inputs for the asset or liability which require the Company’s own assumptions.

As required by SFAS 157, financial assets and liabilities are classified based on the lowest level of input that is significant to the fair value measurement.  Our assessment of the significance of a particular input to the fair value measurement requires judgment, and may affect the valuation of the fair value of assets and liabilities and their placement within the fair value hierarchy levels

The following table summarizes the valuation of our financial instruments by SFAS 157 input levels as of June 30, 2008:

Reclassification -  Certain amounts in the prior year have been reclassified to conform to the current year presentation.  Such reclassifications had no effect on the previously reported net loss.

2.      Employee Stock Options

The Company currently sponsors a stock based compensation plan as described below.  Effective January 1, 2006, the Company adopted the provisions of Statement of Financial Accounting Standards (“SFAS”) No. 123 (Revised), “Share-Based Payment.”  In accordance with the provisions of SFAS No. 123(R), stock based compensation is measured at the grant date based on the value of the awards and is recognized as expense over the requisite service period (usually the vesting period).  The fair values of the stock awards recognized under SFAS No. 123(R) are determined based on each separately vesting portion of the awards, however, the total compensation expense is recognized on a straight-line basis over the vesting period.  The Company has a policy of issuing new shares for stock option exercises.

In accordance with the provisions of SFAS No. 123(R), there was $13,965 and $32,568 in stock based compensation expense recorded in the three and six months ended June 30, 2008.

Employee Stock Option Plan

In May 2005, the Company adopted the 2005 Stock Option Plan (the “Plan”) for employees, officers, directors, consultants and other key personnel.  When the Plan was implemented there were options to purchase 1,000,000 shares common stock available to be be granted under the Plan.  In the first quarter of 2007, the Company increased the number of options to purchase to 2,000,000 shares of common stock.

The Company granted 400,000 share options in June 2006 under the Plan.  The share options became exercisable at a rate of 100,000 per year beginning in September 2006.  The fair value of the options issued was estimated at the date of the grant using the Black-Scholes option pricing model with the following assumptions:  risk free interest rate of 5.14%; dividend yield of 0%, volatility factors of 238%, the expected market price over the estimated life of the option of 6.25 years.  In January 2007, the unvested portion of this grant was cancelled.  The calculated fair value of the portion of the option grant that remained was $26,813.  The Company recognized the full expense in 2006.

The Company granted 100,000 share options in January 2007 under the Plan.  The share options became exercisable upon the grant date.  The fair value of the options issued was estimated at the date of the grant

8

Table of Contents

using the Black-Scholes option pricing model with the following assumptions:  risk free interest rate of 4.68%; dividend yield of 0%, volatility factors of 241%, the expected market price over the estimated life of the option of 5.5 years.  The calculated fair value of the option grant was $19,916.  The Company recognized the expense in the first quarter 2007.

Additionally, the Company granted 870,000 share options in January 2007 under the Plan.  The share options will become exercisable at a rate of 290,000 per year beginning in December 2007.  The fair value of the options issued was estimated at the date of the grant using the Black-Scholes pricing model with the following assumptions:  risk free interest rate of 4.68%, dividend yield of 0%, volatility factors of 243%, the expected market price over the estimated life of the option of 6 years.  The calculated fair value of the option grants was $173,567.  The Company is recognizing the expense of over the three year vesting period of the options.

The Company granted 11,000 share options in February 2007 under the Plan.  The share options will become exercisable in February 2008.  The fair value of the options issued was estimated at the date of the grant using the Black-Scholes option pricing model with the following assumptions:  risk free interest rate 4.77%, dividend yield of 0%, volatility factors of 234% the expected market price over the estimated life of the option of 5.5 years.  The calculated fair value of the option grants was $2,188.  The Company is recognizing the expense over the vesting period of the options.

The Company granted 60,000 share options in March 2007 under the Plan.  The share options will become exercisable at a rate of 30,000 per year beginning in March 2008.  The fair value of the options issued was estimated at the date of the grant using the Black-Scholes pricing model with the following assumptions:  risk free interest rate of 4.5%, dividend yield 0%, volatility factors of 247%, the expected market price over the estimated life of the options of 5.75 years.  The calculated fair value of the option grants was $25,132.  The Company is recognizing the expense over the two year vesting period of the options.

As of June 30, 2008 there was $77,805 of total unrecognized compensation cost related to nonvested share based compensation arrangements granted under the Plan.

The Company’s nonvested share options as of March 31, 2008 and changes during the three months ended June 30, 2008, is summarized as follows:

Employee stock option activity is summarized as follows:

9

Table of Contents

3.      2007 Equity Incentive Plan

In July 2007, the Company adopted the 2007 Equity Incentive Plan (“Equity Plan”).  The Equity Plan provides for the granting of Nonqualified Stock Options, Incentive Stock Options, Stock Appreciation Rights (or SARs), Restricted Stock, Performance Units and Performance Shares to employees, consultants and directors.  The purpose of the Equity Plan is to promote the success and to enhance the value of the Company by aligning the interest of Participants with those of the Company’s shareholders, to provide flexibility to the Company in its ability to motivate, attract, and retain the services of outstanding individuals, upon whose judgment, interest, and special effort the success of the Company is largely dependent.  When the Equity Plan was implemented there were 1,000,000 common shares available to be granted under the Equity Plan.  In the three months ended June 30, 2008, a total of 163,330 performance unit shares had been granted under the Equity Plan to legal consultants of the Company.  The $23,233 expense is included in other professional fees.

4.      Segment Reporting

SFAS No. 131, “Disclosures about Segments of an Enterprise and Related Information”, established standards for reporting information about operating segments in annual financial statements and required selected information about operating segments in interim financial reports issued to stockholders.  It also established standards for related disclosures about products and services, and geographic areas.  Operating segments are defined as components of the enterprise about which separate financial information is available that is evaluated regularly by the chief operating decision maker, or decision making group, in deciding how to allocate resources and in assessing performance.

The Company develops, manufactures, markets and sells high technology dental products, such as air abrasive equipment and curing lights as well as, tooth whitening products.  AMT markets its dental products through dealers and independent distributors to general dental practitioners and certain other dental specialists.  Internationally, the Company continues to sell its products through international distributor networks.  AMT presently markets its industrial products through independent distributors.  The reportable segments are reviewed and managed separately because selling techniques and market environments differ from selling domestically versus selling through international distributor networks.  The remaining revenues of the Company, which are reported as “Other”, represent royalty income.

The accounting policies of the business segments are consistent with those used in prior years.

10

Table of Contents

5.      Comprehensive Income

Total comprehensive income, net of the related estimated tax, was $169,379 and $175,309 for the three and six month periods ended June 30, 2008.  The components of other comprehensive loss for 2008 are net loss and foreign currency translation.

6.      Line of Credit

On December 21, 2006, the Company entered into a secured line of credit agreement with Texas State Bank.  The funds available under the line of credit were $600,000.  The Company invested $300,000 with funds drawn against the line of credit in a Certificate of Deposit with a term of one year as collateral for the loan.  Interest on the line of credit is set at the prime rate plus 1%.  The principal on the loan was payable in one payment on December 20, 2007, with interest on the outstanding amount payable monthly.  In February 2007, Texas State Bank increased the line of credit to $800,000 using the Company’s accounts receivable and inventory as additional collateral.  The terms of the original line of credit remained the same with the exception of the payment date  being extended to February 2008.  In January 2008, the Company renewed the secured line of credit agreement.  The terms of the original line of credit remained the same

11

Table of Contents

with the exception of the payment date which was extended to January 2009.  The interest rate on the line of credit was 6.0% as of June 30, 2008.  The balance outstanding was $630,000 at June 30, 2008.

7.      Income Taxes

FIN 48 - In June 2006, FASB Interpretation (FIN) No. 48, “Accounting for Uncertainty in Income Taxes”, an interpretation of FASB Statement 109 “Accounting for Income Taxes”, was issued.  FIN No. 48 describes accounting for uncertainty in income taxes, and includes a recognition threshold and measurement attribute for recognizing the effect of a tax position taken or expected to be taken in a tax return.  FIN No. 48 is effective for fiscal years beginning after December 15, 2006.  The Company adopted FIN No. 48 on January 1, 2007, and the initial adoption of this Statement had no material impact on the Company’s financial position, results of operations or cash flows.  The tax years still open for examination by Federal and major state agencies as of June 30, 2008 are 2003 – 2006.

8.      Related Party Transactions

Roger Dartt —In consideration of his continued work during the three month period ended March 31, 2007, the Company agreed to issue 200,000 shares of common stock to Mr. Dartt.  The common stock was issued in August 2007.  The Company recorded an estimated expense of $78,000 for the stock issuance in the first quarter of 2007.  The Company issued 200,000 restricted shares of common stock to Mr. Dartt and made an adjustment to the actual expense of $60,000 in September 2007.

9.      Other Events

Detailer Agreement – Dent’NCo   On March 20, 2008 the Company entered into a three year Authorized Detailer Agreement with Dent’NCo, a French company, under which the Company became an authorized broker and detailer of Dent’NCo’s Flexiwhite Tooth Whitening Light and related accessories.  The Company was appointed as an exclusive authorized detailer in certain international markets.  In consideration of the Company’s efforts to develop and retain an international dealer network, Dent’NCo will pay the Company monthly commission for all products sold in the AMT managed territory during the agreement period.

License Agreement – Sheervision, Inc.   On October 24, 2007, the Company entered into a one year Authorized Detailer Agreement with Sheervision, Inc. (“Sheervision”), a Delaware corporation, under which the Company became an authorized broker and detailer of Sheervision’s Firefly Infinity LED Headlight and all related accessories.  The agreement will be renewed for an additional one or two year period in 2008.  The Company was appointed as an exclusive authorized detailer in certain international markets and as a non-exclusive authorized detailer in Sheervision’s retained territory, excluding the United States of America.  In consideration of the Company’s efforts to develop and retain an international dealer network, Sheervision will pay the Company a monthly management fee during the first four months of the agreement and a commission for all products sold in the AMT managed territory during the agreement period.

License Agreement CrownBeav LLC – DirectCrown product line   On April 1, 2007, the Company entered into a License Agreement with CrownBeav LLC, an Oregon limited liability company, under which the Company became the nonexclusive distributor for the United States and Canada and the exclusive distributor for the rest of the world of its DirectCrown brand of temporary crown and bridge material.  The license agreement is for a term of ten years with automatic renewals for additional five year terms, contains minimum requirements for sale of the products by the Company, and may be terminated (i) for cause upon 60 days notice, (ii) upon the Company’s failure to comply with applicable securities laws, (iii) upon the occurrence of certain other customary events of default.  In full consideration, the Company granted to CrownBeav a five year option to purchase (the “Option”) 1,000,000 shares of common stock at $0.20 per share.  The shares subject to the Option will vest two years from the Effective Date of the agreement.  The option agreement includes a guaranteed trading price of $0.40 per share for the 30-day period prior to vesting.  Additional option shares will be granted for the difference if the market price of the shares is below $0.40 during the 30-day period.

12

Table of Contents

The Black-Scholes option pricing model was used to determine the fair value of the options issued to CrownBeav with the following assumptions:  risk free interest rate of 4.54%; dividend yield of 0%; volatility factors of 139%, the expected market price of the Company’s common shares over the estimated life of the option of 3.5 years.  The resulting fair value of the call option was $341,726.  The option grant vests on April 1, 2009.  The option agreement includes a guaranteed trading price of $0.40 per share for the 30-day period prior to vesting.  Additional options will be granted for the difference if the market price is below $0.40 during the 30-day period.  The Black-Scholes option pricing model was used to determine the fair value of the option guarantee issued to CrownBeav with the following assumptions:  risk free interest rate of 4.60%; dividend yield of 0%; volatility factors of 100%, the expected market price of the Company’s common shares over the guarantee period of 2 years.  The resulting fair value of the put option was $185,000.  The $526,726 fair market value of the option (combination of call and put) was capitalized as an intangible asset and is being recognized as a licensing fee over the 10 year period of the license.

On May 9, 2008, the building at 5655 Bear Lane, Corpus Christi, Texas was sold by Bear Street Associates LLC (“Bear Street”, formerly Sepulveda Group) and the lease between Bear Street and AMT was terminated.  In consideration of the early lease termination, AMT entered into an agreement to pay $250,000 over a 10 month period beginning in June 2008.  The Company fully recognized the deferred gain on the 2006 sale of the building and the lease termination fee in other income in the quarter ended June 30, 2008.  The recognized gain offset by the lease termination fee is recorded in other income.  The Company entered into three year lease agreement with WTF Properties LLC effective May 9, 2008 and will continue to occupy a portion of the building.

ITEM 2.     MANAGEMENT’S DISCUSSION AND ANALYSIS OF FINANCIAL CONDITION AND RESULTS OF OPERATIONS

Forward Looking Statements

The Company makes forward-looking statements in this report and may make such statements in future filings with the Securities and Exchange Commission.  The Company may also make forward-looking statements in its press releases or other public shareholder communications.  The Company’s forward-looking statements are subject to risks and uncertainties and include information about its expectations and possible or assumed future results of operations.  When the Company uses any of the words “believes”, “expects”, “anticipates”, “estimates” or similar expressions, it is making forward-looking statements.

To the extent available, the Company claims the protection of the safe harbor for forward-looking statements contained in the Private Securities Litigation Reform Act of 1995 for all of its forward-looking statements.  While the Company believes that its forward-looking statements are reasonable, you should not place undue reliance on any such forward-looking statements, which speak only as of the date made.  Because these forward-looking statements are based on estimates and assumptions that are subject to significant business, economic and competitive uncertainties, many of which are beyond the Company’s control or are subject to change, actual results could be materially different.  Factors that might cause such a difference include, without limitation, the following:  the Company’s inability to generate sufficient cash flow to meet its current liabilities, the inability of the Company to find suitable new acquisitions or the expense or difficulty of integrating such acquisitions with current Company operations, adverse results in any of the Company’s material lawsuits, the possible failure of revenues to offset additional costs associated with its new business model, the potential lack of product acceptance, the Company’s potential inability to introduce new products to the market, the potential failure of customers to meet purchase commitments, the potential loss of customer relationships, the potential failure to receive or maintain necessary regulatory approvals, the extent to which competition may negatively affect prices and sales volumes or necessitate increased sales expenses, the failure of negotiations to establish original equipment manufacturer agreements or strategic alliances and the other risks and uncertainties set forth in this report.

Other factors not currently anticipated by management may also materially and adversely affect the Company’s results of operations.  Except as required by applicable law, the Company does not undertake

13

Table of Contents

any obligation to publicly release any revisions which may be made to any forward-looking statements to reflect events or circumstances occurring after the date of this report.

Critical Accounting Policies

The preparation of financial statements in conformity with accounting principles generally accepted in the United States requires the Company to make estimates and assumptions that affect amounts reported in the accompanying consolidated financial statements and related footnotes.  These estimates and assumptions are evaluated on an on-going basis based on historical developments, market conditions, industry trends and other information the Company believes to be reasonable under the circumstances.  There can be no assurance that actual results will conform to the Company’s estimates and assumptions, and that reported results of operations will not be materially adversely affected by the need to make accounting adjustments to reflect changes in these estimates and assumptions from time to time.  The policies the Company believes to be the most sensitive to estimates and judgments are described in Item 7 of the Company’s 2007 Annual Report on Form 10-KSB.

Results of Operations

The Company had revenues of $687,826 for the three month period ended June 30, 2008 compared to $827,473 for the same period in 2007, a decrease of 17%.  For the three month period ended June 30, 2008, domestic revenues decreased 9% and international revenues decreased 34% compared to the same period in 2007.  The decrease in revenues included a $110,000 decrease in the industrial product line due to two international orders totaling $95,000 in 2007.  Additionally, 2007 included a $50,000 sale of inventory previously included in the inventory reserve.  Revenues for parts and repairs decreased approximately $33,800 which is related to the historical decrease in equipment sales.  The decreases in revenues were partially offset by a $32,800 increase in KCP revenues and a $26,700 increase in PAC revenues for an international sale in the period ended June 30, 2008.

The Company had revenues of $1,324,121 for the six month period ended June 30, 2008 compared to $1,682,591 for the same period in 2007, a decrease of 21%.  For the six month period ended June 30, 2008, domestic revenues decreased 17% and international revenues decreased 29% compared to the same period in 2007.  The decrease in revenues included a $127,900 decrease in revenues in the industrial product line, primarily due to two international orders totaling $95,000 in 2007.  For the six month period ended June 30, 2008 the Company experienced a $149,400 decrease in Spectrum product line sales primarily due to underperformance in Latin America, the transition of sales through a master distributor to smaller distributors in Europe and changes in distribution in Asia.  Revenues for parts and repairs decreased $94,200 which is related to the historical decrease in equipment sales.  Additionally, the period in 2007 included $94,000 in sales of inventory previously included in the inventory reserve.  The decreases in revenues were partially offset by a $33,900 increase PAC product line revenues and a $49,000 increase in Direct Crown product line that was added in April 2007.

The Company anticipates a continued decrease in the sale of parts and repairs and an increase in revenues for DirectCrown and other recently added brokered product lines.  The Company is actively pursuing new international distributors for its Spectrum tooth whitening product line and expects an increase in revenues.

Additionally, royalties were $8,942 and $12,556 for the three and six month periods ended June 30, 2008 compared to $0 and $6,063 for the same periods in 2007.

Gross profit as a percentage of revenues was 68% and 69% for the three and six month periods ended June 30, 2008 compared to 62% and 63% for the same periods in 2007.  The increase in gross profit for the three and six month periods ended June 30, 2008 was primarily attributable to the sale and use of approximately $17,900  and  $37,800 in inventory previously included in the inventory valuation allowance.  Additionally, gross profit increased in the PAC product line and due to revenues received as commissions on brokered product lines.  These increases were partially offset by the sale of $94,000 in inventory previously included in the reserve in 2007.  The Company expects the gross profit to continue to increase as additional

14

Table of Contents

inventory included in the inventory valuation allowance is used or sold and with the continued growth in revenues from brokered product lines.

Selling, general and administrative expenses were $524,029 and 1,161,318 for the three and six month periods ended June 30, 2008 compared to $671,375 and $1,441,971 for the same periods in 2007, a decrease of 22% and 19% respectively.  Payroll expense decreased $113,400 for the six month period ended June 30, 2008 due to changes in personnel.  Marketing expenses decreased $25,000 and $12,200 for the three and six month periods ended June 30, 2008 when compared to the same periods in 2007.  This decrease is primarily attributable to limited international marketing travel in 2008.  Other professional fees decreased $67,300 and $78,600 for the three and six month periods ended June 30, 2008 compared to the same periods in 2007.  These decreases are primarily attributable to a decrease in legal expense and consulting fees.  The Company is diligently working to continue to reduce selling, general and administrative expenses.

The Company had no research and development expenses in the three and six month periods ended June 30, 2008 compared to $1,634 and $10,846 for the same periods in 2007.  The Company does not anticipate the development of new product lines for manufacturing.

Other income was $229,640 and $259,009 for the three and six month periods ended June 30, 2008 compared to $59,308 and $102,201 for the same periods in 2007.  The increase in other income is primarily attributable to the recognition of $452,200 in May 2008 of the remaining deferred gain on the sale of the building which was partially offset by a $250,000 early lease termination fee.  Additionally, the three and six month periods ended June 30, 2008 included a  decrease in fees received for consulting services.  The Company does not expect additional fees for consulting services for the remainder of 2008.  In addition, the Company anticipates a decrease in other income due to the termination of a sublease in May 2008.

Liquidity and Capital Resources

The Company’s operating activities used $52,590 for the six month period ended June 30, 2008.

The Company’s investing activities used $4,396 for the six month period ended June 30, 2008.

The Company’s financing activities provided $130,000 for the six month period ended June 30, 2008 in funds received from the Company’s line of credit with Texas State Bank.

On December 21, 2006, the Company entered into a secured line of credit agreement with Texas State Bank.  The funds available under the line of credit were $600,000.  The Company invested $300,000 with funds drawn against the line of credit in a Certificate of Deposit with a term of one year as collateral for the loan.  Interest on the line of credit is set at the prime rate plus 1%.  The principal on the loan was payable in one payment on December 20, 2007, with interest on the outstanding amount payable monthly.  In February 2007, Texas State Bank increased the line of credit to $800,000 using the Company’s accounts receivable and inventory as additional collateral.  The terms of the original line of credit remained the same with the exception of the payment date  being extended to February 2008.  In January 2008, the Company renewed the secured line of credit agreement.  The terms of the original line of credit remained the same with the exception of the payment date which was extended to January 2009.  The interest rate on the line of credit was 6.0% as of June 30, 2008.  The balance outstanding was $630,000 at June 30, 2008.

On April 11, 2006, the Company entered into a licensing agreement with Discus Dental Holdings, Inc. (“Discus”) and its wholly owned subsidiary, Spectrum Dental, Inc. (“Spectrum Dental”), a leading provider of professional tooth whitening products under the brand names of “Contrastpm”, “Contrastpmplus” and “Contrastam”, under which AMT became the exclusive distributor of the Spectrum Dental product line, which provided  approximately $933,000 in additional revenue in 2006.  The Sepulveda Group, LLC is affiliated with Discus.  In full payment for the license, the Company issued Discus a warrant to purchase 2,500,000 shares of common stock at $0.20 per share.

15

Table of Contents

The fair value of the warrants issued to Discus is estimated at the end of each period using the Black-Scholes option pricing model with the following assumptions used on June 30, 2008:  risk free interest rate of 3.34%; dividend yield of 0%; volatility factors of 250%, the expected market price of the Company’s common shares over the estimated life of the warrant of 6.5 years.  The calculated fair value of the warrant as of December 31, 2007 was $449,412.  The calculated fair value of the warrant on the grant date was $549,530 which the Company capitalized as an intangible asset and is recognizing as a licensing fee over the vesting period of five years.

On April 1, 2007, the Company entered into a License Agreement with CrownBeav LLC, an Oregon limited liability company, under which the Company became the nonexclusive distributor for the United States and Canada and the exclusive distributor for the rest of the world of it’s DirectCrown brand of temporary crown and bridge material.  The license agreement is for a term of ten years with automatic renewals for additional five year terms, contains minimum requirements for sale of the products by the Company, and may be terminated (i) for cause upon 60 days notice, (ii) upon the Company’s failure to comply with applicable securities laws, (iii) upon the occurrence of certain other customary events of default.  In full consideration, the Company granted to CrownBeav a five year option to purchase (the “Option”) 1,000,000 shares of common stock at $0.20 per share.  The shares subject to the Option will vest two years from the Effective Date of the agreement.  The option agreement includes a guaranteed trading price of $0.40 per share for the 30-day period prior to vesting.  Additional option shares will be granted for the difference if the market price of the shares is below $0.40 during the 30-day period.

The Black-Scholes option pricing model was used to determine the fair value of the options issued to CrownBeav with the following assumptions:  risk free interest rate of 4.54%; dividend yield of 0%; volatility factors of 139%, the expected market price of the Company’s common shares over the estimated life of the option of 3.5 years.  The resulting fair value of the call option was $341,726.  The option grant vests on April 1, 2009.  The option agreement includes a guaranteed trading price of $0.40 per share for the 30-day period prior to vesting.  Additional option shares will be granted for the difference if the market price is below $0.40 during the 30-day period.  The Black-Scholes option pricing model was used to determine the fair value of the option guarantee issued to CrownBeav with the following assumptions:  risk free interest rate of 4.60%; dividend yield of 0%; volatility factors of 100%, the expected market price of the Company’s common shares over the guarantee period of 2 years.  The resulting fair value of the put option was $185,000.  The $526,726 fair market value of the option (combination of call and put) was capitalized as an intangible asset and is being recognized as a licensing fee over the 10 year period of the license.

On October 24, 2007, the Company entered into a one year Authorized Detailer Agreement with Sheervision, Inc. (“Sheervision”), a Delaware corporation, under which the Company became an authorized broker and detailer of Sheervision’s Firefly Infinity LED Headlight and all related accessories.  The agreement will be renewed for an additional one or two year period in 2008.  The Company was appointed as an exclusive authorized detailer in certain international markets and as a non-exclusive authorized detailer in Sheervision’s retained territory, excluding the United States of America.  In consideration of the Company’s efforts to develop and retain an international dealer network, Sheervision will pay the Company a monthly management fee during the first four months of the agreement and a commission for all products sold in the AMT managed territory during the agreement period.

On March 20, 2008 the Company entered into a three year Authorized Detailer Agreement with Dent’NCo, a French company, under which the Company became an authorized broker and detailer of Dent’NCo’s Flexiwhite Tooth Whitening Light and related accessories.  The Company was appointed as an exclusive authorized detailer in certain international markets.  In consideration of the Company’s efforts to develop and retain an international dealer network, Dent’NCo will pay the Company monthly commission for all products sold in the AMT managed territory during the agreement period.

The Company has suffered recurring losses from operations, and its total liabilities exceed its total assets. This raises substantial doubt about the Company’s ability to continue as a going concern. The Company’s ability to generate positive operational cash flow is dependent upon increasing revenues through the sales of existing product lines and the expansion related to the representation of additional lines of dental

16

Table of Contents

products.  While the Company has identified additional product lines and has ongoing dialogs with dental product manufacturers, there can be no assurance that the Company will be successful in finalizing the contract for representation of these products or that the Company will be successful in generating a positive operational cash flow.

ITEM 3                   QUANTITATIVE AND QUALITATIVE DISCLOSURES ABOUT MARKET RISK

None required.

ITEM 4T           CONTROLS AND PROCEDURES

The Company’s management, with the participation of the chief executive officer and principal accounting officer, evaluated the effectiveness of our disclosure controls and procedures (as defined in Rules 13a-15(e) and 15d-15 under the Exchange Act) as of June 30, 2008.  Based upon this evaluation, the chief executive officer and principal accounting officer concluded that the Company’s disclosure controls and procedures were effective.  Subsequent to the evaluation and through the date of this filing of Form 10-Q for the three month period ended June 30, 2008, there have been no significant changes in the Company’s internal controls over financial reporting (as defined in Rules 13a-15(f) and 15-d-15(f) under the Exchange Act) or in any other factors that could significantly affect these controls.

PART II              OTHER INFORMATION

ITEM 1                   LEGAL PROCEEDINGS

In the normal course of business, we may become involved in various legal proceedings.  As of June 30, 2008, we know of no pending or threatened legal proceeding to which we are or will be a party which, if successful, might result in material adverse change in our business properties or financial condition.  However, as with most businesses, we are occasionally parties to lawsuits incidental to our business, none of which are anticipated to have a material adverse impact on our financial position, results of operations, liquidity or cash flows.  We estimate the amount of potential exposure it may have with respect to litigation claims and assessments.

ITEM 1A         RISK FACTORS

Not required

ITEM 2                   UNREGISTERED SALES OF EQUITY SECURITIES AND USE OF PROCEEDS

In the three months ended June 30, 2008, a total of 163,330 performance unit shares had been granted under the Company’s 2007 Equity Incentive Plan to legal consultants of the Company.

ITEM 3                   DEFAULTS UPON SENIOR SECURITIES

None

ITEM 4                   SUBMISSION OF MATTERS TO A VOTE OF SECURITY HOLDERS

None

ITEM 5                   OTHER INFORMATION

None

17

Table of Contents

ITEM 6                   EXHIBITS

Exhibit Index

18

Table of Contents